Foresite Capital Management Vi LLC Portfolio Holdings

Foresite Capital Management Vi LLC

  • $178 Billion
  • Q2 2025

Foresite Capital Management Vi LLC has filed its 13F form on August 12, 2025 for Q2 2025 where it was disclosed a total value porftolio of $178 Billion distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cg Oncology, Inc. with a value of $57.8B, Centessa Pharmaceuticals PLC with a value of $16.5B, Akero Therapeutics, Inc. with a value of $13.1B, Alumis Inc with a value of $12.7B, and Rapt Therapeutics Inc with a value of $12.5B.

Examining the 13F form we can see an decrease of $4.66B in the current position value, from $183B to 178B.

Foresite Capital Management Vi LLC is based out at Larkspur, CA

Below you can find more details about Foresite Capital Management Vi LLC portfolio as well as his latest detailed transactions.

Portfolio value $178 Billion
Healthcare: $67.4 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
Cg Oncology, Inc.
-
$57.8 Billion 32.47% of portfolio
-
Q4 2024 New
$1.61B
$16.5 Billion 9.26% of portfolio
1,253,379
Q4 2024 New
$2.23B
$13.1 Billion 7.35% of portfolio
244,900
Q2 2025 Reduced 32.9%
Alumis Inc
-
$12.7 Billion 7.16% of portfolio
-
Q2 2025 Added 1.07%
Rapt Therapeutics Inc
-
$12.5 Billion 7.03% of portfolio
-
Q2 2025 New
Bicara Therapeutics Inc
-
$8.82 Billion 4.96% of portfolio
-
Q2 2025 Reduced 0.08%
$846M
$7.67 Billion 4.31% of portfolio
585,000
Q4 2024 New
Hinge Health Inc
-
$6.99 Billion 3.93% of portfolio
-
Q2 2025 New
$209M
$6.92 Billion 3.89% of portfolio
1,731,233
Q2 2025 Added 9.49%
$2.18B
$6.39 Billion 3.59% of portfolio
146,332
Q4 2024 New
Verastem Inc
-
$5.3 Billion 2.98% of portfolio
-
Q2 2025 New
$2.24B
$5.01 Billion 2.82% of portfolio
160,000
Q2 2025 New
$332M
$4.47 Billion 2.51% of portfolio
594,025
Q2 2025 Reduced 6.39%
Structure Therapeutics Inc
-
$4.36 Billion 2.45% of portfolio
-
Q2 2025 Reduced 50.0%
$148M
$3.25 Billion 1.83% of portfolio
2,875,357
Q2 2025 Reduced 16.61%
$1.13B
$3.04 Billion 1.71% of portfolio
144,468
Q2 2025 New
Spyre Therapeutics Inc
-
$1.05 Billion 0.59% of portfolio
-
Q2 2025 New
Casi Pharmaceuticals Inc
-
$929 Million 0.52% of portfolio
-
Q2 2025 Reduced 40.79%
$717M
$27.6 Million 0.02% of portfolio
1,974
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 20
  • Current Value $178 Billion
  • Prior Value $183 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 12, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 7 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Foresite Capital Management Vi LLC Portfolio

Follow Foresite Capital Management Vi LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management Vi LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management Vi LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email